Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

CollPlant Biotechnologies (CLGN) Revenue (2017 - 2025)

Historic Revenue for CollPlant Biotechnologies (CLGN) over the last 9 years, with Q3 2025 value amounting to $77000.0.

  • CollPlant Biotechnologies' Revenue rose 182500.0% to $77000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 million, marking a year-over-year increase of 28076.92%. This contributed to the annual value of $515000.0 for FY2024, which is 9530.07% down from last year.
  • As of Q3 2025, CollPlant Biotechnologies' Revenue stood at $77000.0, which was up 182500.0% from $179000.0 recorded in Q2 2025.
  • Over the past 5 years, CollPlant Biotechnologies' Revenue peaked at $43.0 billion during Q3 2023, and registered a low of $4000.0 during Q3 2024.
  • Moreover, its 5-year median value for Revenue was $214000.0 (2024), whereas its average is $2.4 billion.
  • Per our database at Business Quant, CollPlant Biotechnologies' Revenue surged by 3944944128.44% in 2023 and then tumbled by 10000.0% in 2024.
  • Over the past 5 years, CollPlant Biotechnologies' Revenue (Quarter) stood at $310000.0 in 2021, then plummeted by 81.29% to $58000.0 in 2022, then skyrocketed by 415.52% to $299000.0 in 2023, then crashed by 45.15% to $164000.0 in 2024, then plummeted by 53.05% to $77000.0 in 2025.
  • Its Revenue stands at $77000.0 for Q3 2025, versus $179000.0 for Q2 2025 and $2.1 million for Q1 2025.